Homeo AI vs DigiHomeo: Pay-per-Use AI or Review Copilot?

Quick answer

Choose DigiHomeo when the main job is combining cloud case records, multilingual access, Miasm Finder, AI-assisted analysis, a practitioner-discovery directory, and pay-per-use credits in one web and Android workflow. Choose Homeo AI when the main job is turning a completed case narrative into an inspectable review chain through proposed symptoms, editable rubric mappings, linked source passages, remedy differentiation, and follow-up reasoning.

The pricing models cannot be compared as a single monthly number. DigiHomeo's homepage reviewed on 10 August 2026 says patient profiles and case history are free and AI credits start at USD 20. Its terms say an AI analysis consumes one credit and no monthly subscription is required. The public pages do not state how many paid credits are included in the starting amount, whether credits expire, or whether taxes, payment fees, and local currency conversion change the checkout total. Obtain the live credit bundle and written expiry or refund rules before calculating cost per reviewed case.

DigiHomeo's current first-party pages also make broad claims about security, compliance, remedy analysis, and clinical performance. They are vendor claims, not an independent audit or evidence of clinical accuracy. A clinic should turn each claim into a test or contract question rather than repeating it as a verified outcome.

What DigiHomeo currently offers

The official Google Play listing identifies DigiHomeo as a professional tool for licensed homeopathic practitioners. It was updated on 3 August 2026, shows in-app purchases and more than 1,000 downloads, and advertises five free AI credits for new practitioners. The vendor's terms, dated 27 June 2026, describe a web progressive app, Android app, and installable iOS web app that require an internet connection.

The product combines several jobs. Practitioners can create patient records, document case history and follow-ups, run AI-assisted remedy analysis, use a Miasm Finder based on a ten-miasm framework, generate reports, and maintain a public profile for discovery by patients. The vendor lists English, Urdu, Hindi, Bengali, Nepali, Spanish, French, Portuguese, German, and Arabic.

That breadth is DigiHomeo's genuine advantage. A practitioner who wants records, analysis, multilingual access, and a directory inside one account may prefer it to assembling separate products. Pay-per-use credits can also suit an occasional user who does not want another fixed subscription, provided the bundle quantity, expiry, refunds, and actual annual usage are clear.

The directory feature should be evaluated separately from the analysis engine. DigiHomeo's own terms tell patients to verify a practitioner's licence and say the platform does not guarantee that every listed profile is currently licensed. A clinic listing itself should confirm how credentials are reviewed, how impersonation is reported, what information becomes public, and how a profile is removed after closure or a staff departure.

Miasm Finder and multilingual use need their own tests

DigiHomeo presents Miasm Finder as a structured analysis of mental, physical, family, and past-history inputs. That can be useful to practitioners whose method explicitly uses such a framework. It does not establish that the scoring is stable, that every input has the intended weight, or that the result is clinically valid.

Run the same completed case twice without changing the text, then repeat it with harmless changes in word order. Record whether the miasm scores and ranked suggestions remain stable. Remove one important input at a time and check whether the change is visible and proportionate. Ask whether the interface shows which phrases or fields affected each score and whether the practitioner can correct a mistaken interpretation before it enters a report.

Multilingual availability is similarly testable. A translated interface is different from reliable interpretation of colloquial clinical language. Use a de-identified bilingual case set in which a practitioner has approved both versions. Check negation, intensity, time sequence, local idioms, mental symptoms, modalities, and anatomical language. Compare the extracted structure and ranked output across languages. A ten-language product claim should not be treated as ten-language clinical validation.

How Homeo AI differs

Homeo AI is narrower. It begins with the original case narrative and makes the review path the central object. The practitioner can inspect proposed symptom structure, accept, edit, or reject rubric mappings, open linked source passages, compare remedy differences, and retain reviewed reasoning for follow-up.

That is a different priority from an all-in-one cloud clinic account. DigiHomeo may reduce tool switching by combining records, discovery, miasm scoring, AI analysis, and multilingual access. Homeo AI may be the better fit when the practice already has an operational record system and wants another practitioner to reconstruct why a phrase became a symptom, why a rubric was retained, and which source passage supported the differential.

Neither product should receive credit for the other's exact workflow. Homeo AI should not be described as offering DigiHomeo's directory, ten-language interface, credit scheme, or Miasm Finder. DigiHomeo should not be assumed to preserve Homeo AI's exact narrative-to-rubric correction trail merely because its output includes reasoning.

Price the work, not the headline

Start with a representative month of completed cases. For DigiHomeo, record every action that consumes a credit, the number of retries caused by incomplete inputs or corrections, any free-credit restrictions, the purchased bundle, unused balance, expiry, refund status, payment fee, and tax. The terms say one AI request uses one credit, while the homepage says credits start at USD 20. Those statements do not establish the number of usable analyses in the starting purchase.

Also test what remains available when the credit balance reaches zero. Confirm that records, exports, prior analyses, and follow-up history remain readable. Ask whether re-opening an existing case, changing one field, regenerating a report, or using Miasm Finder triggers another charge. Preserve a dated checkout screenshot and receipt rather than relying on a search snippet.

For Homeo AI, measure the plan actually offered to the clinic, the number of practitioners, case volume, source access, exports, support, and time spent reviewing mappings. Compare total annual cost and practitioner review time, not one vendor's credit headline with another vendor's subscription headline.

Privacy and procurement questions

DigiHomeo's public privacy page is labelled 5 October 2026, a date later than this 10 August review. That future date cannot prove a current policy update. The page also uses general categories such as AI processing, payments, email, and analytics instead of naming the processors, hosting regions, model providers, retention periods, or contract terms that apply to clinical text.

The page says data can cross borders, describes encryption in transit and at rest, and uses HIPAA and GDPR language. These are useful diligence prompts, not proof that a specific clinic account has a business associate agreement, a data-processing agreement, configured regional storage, or independently audited controls. Ask for the current legal entity, corrected effective date, subprocessor list, hosting and inference locations, retention schedule, backup-deletion period, model-training rule, incident terms, export format, and account-closure process.

Until those answers and the clinic's own obligations are resolved, use only completed, de-identified cases. Remove names, dates of birth, contact details, record numbers, exact visit dates, photographs, rare occupations, locations, and combinations that could identify a person. Do not assume that a general compliance badge authorizes identifiable patient data.

A reproducible clinic test

Prepare eight completed, de-identified cases already reviewed by a practitioner. Include two straightforward narratives, two close differentials, one bilingual pair, one follow-up, one case with a deliberately ambiguous modality, and one case in which a historical miasm label is withheld from the test input. Keep an answer packet outside both products containing the original wording, accepted symptom structure, references reviewed, final differential, and documented corrections.

In DigiHomeo, create the cases and record every credit event. Test the same narrative twice, the bilingual pair, Miasm Finder stability, the visibility of source references, correction controls, report export, follow-up continuity, and what data the directory exposes. Stop before entering identifiable data. Record every unsupported statement or important omission and the time needed to repair it.

In Homeo AI, enter the same narratives. Record which proposed symptoms and rubrics are accepted, edited, or rejected, which passages are opened, whether a second practitioner can reconstruct the reasoning, and whether the follow-up remains distinct from the original case. Repeat the bilingual case and compare narrative fidelity rather than merely comparing the top remedy.

Score both products on correction time, source traceability, repeatability, language fidelity, export quality, data exposure, actual annual cost, and the ability to reconstruct a decision. Agreement with a historical prescription is not proof of correctness. A plausible output can still rest on a mistaken translation, unsupported rubric, or unstable score.

Known limits and clinical responsibility

DigiHomeo can produce an appealing recommendation, confidence score, miasm result, or report that still requires careful review. Its current pages contain vendor-supplied claims about diagnosis, outcomes, compliance, and accuracy that have not been independently established by the public sources reviewed here.

Homeo AI can also misread a narrative, propose an unsuitable rubric, omit a relevant passage, or create a plausible differential that needs correction. Showing a reasoning chain makes review easier; it does not make the chain correct.

Neither product replaces diagnosis, referral, an emergency-care decision, practitioner judgment, prescription, potency, dosage, or follow-up responsibility. Urgent, severe, or rapidly worsening symptoms require appropriate medical assessment. The practitioner remains responsible for every accepted interpretation, source, record, and clinical action.

Conditional verdict

Choose DigiHomeo if the tested priority is a multilingual web and Android clinic workspace with free core records, metered AI use, Miasm Finder, and practitioner discovery. Buy credits only after the bundle quantity, expiry, refund, processor, data, and per-action rules are documented.

Choose Homeo AI if the tested priority is a reconstructable path from original narrative to corrected symptom structure, rubric review, source inspection, remedy differentiation, and follow-up. If a clinic uses both, define a one-way handoff that preserves original wording and practitioner-approved corrections without creating two conflicting clinical records.

Official sources checked

• DigiHomeo official product page
• DigiHomeo official terms of service
• DigiHomeo official privacy policy
• DigiHomeo official Google Play listing

Product facts reviewed 2026-08-10. Confirm current features, prices, source libraries, and terms with the vendor.